text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 5625-67-2 | Product Number: P1867

2-Piperazinone


Purity: >98.0%(GC)
Synonyms:
  • Piperazin-2-one
  • 2-Oxopiperazine
Documents:
1G
£14.00
2   2  
5G
£32.00
Contact Us 15  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number P1867
Purity / Analysis Method >98.0%(GC)
Molecular Formula / Molecular Weight C__4H__8N__2O = 100.12  
Physical State (20 deg.C) Solid
Store Under Inert Gas Store under inert gas
Condition to Avoid Hygroscopic
CAS RN 5625-67-2
Reaxys Registry Number 107796
PubChem Substance ID 125307584
MDL Number

MFCD01318687

Specifications
Appearance Light yellow to Yellow to Orange powder to crystal
Purity(GC) min. 98.0 %
Purity(Nonaqueous Titration) min. 96.0 %
Melting point 131.0 to 136.0 °C
Properties (reference)
Melting Point 134 °C
Boiling Point 164 °C/5 mmHg
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
Precautionary Statements P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P302 + P352 : IF ON SKIN: Wash with plenty of water.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P362 + P364 : Take off contaminated clothing and wash it before reuse.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
Related Laws:
Transport Information:
HS Number 2933599590
PubMed Literature


Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents